Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

GLUMON · Next generation in-blood glucose monitoring using non-invasive optoacoustic sensing

HORIZONStatus: SIGNED1 May 202230 April 2026EU funding €2,194,210Call HORIZON-EIC-2021-TRANSITION-CHALLENGES-01

GLUMON aims to leverage a new class of a biomedical optoacoustic sensor developed under the FETOpen project RSENSE (GA #862811) and offer the next generation of non-invasive biochemical in-vivo sensing. The preliminary sensor for non-invasive in-blood glucose sensing has already produced outstanding findings and places the technology well ahead of its competition. Addressing the limitations of existing sensors, mainly accurate non-invasive continuous monitoring of blood-glucose as well as comfort, the GLUMON sensor will better address diabetes healthcare needs. As a secondary goal and contingency plan, GLUMON will exploit this technology as a lipid sensor and build further potential by addressing the emerging precision nutrition market.The objectives of the GLUMON project are to:1) mature the technology from a lab bench-top setup to a functional portable sensor prototype

Consortium · 6 organisations

coordinator

HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH

DE · €852,978

participant

ALIRA HEALTH SL

ES · €150,000

participant

MEDIZINISCHE UNIVERSITAT GRAZ

AT · €320,875

associatedPartner

RAYFOS LTD

UK

participant

KLINIKUM DER TECHNISCHEN UNIVERSITÄT MÜNCHEN (TUM KLINIKUM)

DE · €309,625

participant

STHESIS GMBH

DE · €560,732

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.